Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
| 742.58 Delayed Data As of 4:00pm ET |  0.00 / 0.00%Today’s Change | 538.01 Today|||52-Week Range 779.00 | +2.92% Year-to-Date |
Latest REGN News | Press Releases
| Why Regeneron (REGN) is Poised to Beat Earnings Estimates Again 12:10pm / Zacks.com - Paid Partner Content | Regeneron (REGN) Gains But Lags Market: What You Should Know Jan 23 / Zacks.com - Paid Partner Content |
| Regeneron (REGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher? 10:00am / Zacks.com - Paid Partner Content | Wall Street Thinks These 2 Blazing Healthcare Stocks Could Have 21% to 30% Upside in 2023 Jan 23 / MotleyFool.com - Paid Partner Content |
| Covenant Asset Management, LLC Buys 3, Sells 2 in 4th Quarter Jan 24 / GuruFocus News - Paid Partner Content | Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? Jan 17 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 742.58 |
| Today’s open | 745.61 |
| Day’s range | 740.70 - 748.79 |
| Volume | 19,967 |
| Average volume (3 months) | 670,841 |
| Market cap | $78.6B |
Data as of 4:00pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | +133.99% |
| Earnings growth (this year) | -42.64% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +89.14% |
| P/E ratio | 15.8 |
| Price/Sales | 4.41 |
| Price/Book | 4.18 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VRTXVertex Pharmaceutica... | +0.75 | +0.23% |
| ZTSZoetis Inc | -3.11 | -1.85% |
| ---- | ||
| GSKGlaxoSmithKline | +0.01 | +0.03% |
Data as of 4:00pm ET, 01/27/2023
Financials
| Next reporting date | February 3, 2023 |
| EPS forecast (this quarter) | $10.17 |
| Annual revenue (last year) | $16.1B |
| Annual profit (last year) | $8.1B |
| Net profit margin | 50.25% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Tarrytown, New York |
Forecasts
